Long-term Safety and Efficacy Data With Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study Up to 240 Weeks

Aerodone (aerosol pirfenidone) - Avalyn Pharma

https://www.atsjournals.org/doi/abs/10.1164/ajrccm.2025.211.Abstracts.A2906

Hao Bao, MSc; Felix Woodhead, MD, PhD; Craig S. Conoscenti, MD, FCCP, ATSF; Sebastien Tilleux, PharmD, PhD; Howard M. Lazarus, MD, FCCP; Tamera Jo. Corte, MBBS, BScM, PhD; Deepthi Nair, MS; Margaret L. Wilsher, MD

Feb 24, 2025